Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Seigler, HF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 55 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ackley, CD; Prieto, VG; Bentley, RDC; Horenstein, MG; Seigler, HF; Shea, CR
      Primary chondroid melanoma

      JOURNAL OF CUTANEOUS PATHOLOGY
    2. Zennadi, R; Abdel-Wahab, Z; Seigler, HF; Darrow, TL
      Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: Requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by th2cells

      CELLULAR IMMUNOLOGY
    3. Owen, SA; Sanders, LL; Edwards, LJ; Seigler, HF; Tyler, DS; Grichnik, JM
      Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV

      CANCER
    4. White, RR; Halperin, TJ; Olson, JA; Soo, MS; Bentley, RC; Seigler, HF
      Impact of cove-needle breast biopsy on the surgical management of mammographic abnormalities

      ANNALS OF SURGERY
    5. Onaitis, MW; Noone, RB; Hartwig, M; Hurwitz, H; Morse, M; Jowell, P; McGrath, K; Lee, C; Anscher, MS; Clary, B; Mantyh, C; Pappas, TN; Ludwig, K; Seigler, HF; Tyler, DS
      Neoadjuvant chemoradiation for rectal cancer: Analysis of clinical outcomes from a 13-year institutional experience

      ANNALS OF SURGERY
    6. Vollmer, RT; Seigler, HF
      Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma

      AJCP. American journal of clinical pathology
    7. Yang, SX; Kittlesen, D; Slingluff, CL; Vervaert, CE; Seigler, HF; Darrow, TL
      Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and-A3

      JOURNAL OF IMMUNOLOGY
    8. O'Leary, JA; Berend, KR; Johnson, JL; Levin, LS; Seigler, HF
      Subungual melanoma - A review of 93 cases with identification of prognostic variables

      CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
    9. Tyler, DS; Onaitis, M; Kherani, A; Hata, A; Nicholson, E; Keogan, M; Fisher, S; Coleman, E; Seigler, HF
      Positron emission tomography scanning in malignant melanoma - Clinical utility in patients with Stage III disease

      CANCER
    10. Dong, XD; Tyler, D; Johnson, JL; DeMatos, P; Seigler, HF
      Analysis of prognosis and disease progression after local recurrence of melanoma

      CANCER
    11. Onaitis, MW; Kirshbom, PM; Hayward, TZ; Quayle, FJ; Feldman, JM; Seigler, HF; Tyler, DS
      Gastrointestinal carcinoids: Characterization by site of origin and hormone production

      ANNALS OF SURGERY
    12. Vollmer, RT; Seigler, HF
      A model for pretest probability of lymph node metastasis from cutaneous melanoma

      AJCP. American journal of clinical pathology
    13. DeMatos, P; Seigler, HF
      Monitoring antitumour immune response during immunotherapy of cancer - Whyand how?

      BIODRUGS
    14. Yang, S; Vervaert, CE; Seigler, HF; Darrow, TL
      Tumor cells cotransduced with B7.1 and gamma-IFN induce effective rejection of established parental tumor

      GENE THERAPY
    15. White, DC; Schuler, FR; Pruitt, SK; Culhane, DK; Seigler, HF; Coleman, RE; Tyler, D
      Timing of sentinel lymph node mapping after lymphoscintigraphy

      SURGERY
    16. Dong, XD; Abdel-Wahab, Z; Dematos, P; Fong, T; Pruitt, SK; Seigler, HF
      MCA106 fibrosarcoma cells transduced with granulocyte macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing thegrowth of hepatic metastases

      JOURNAL OF SURGICAL ONCOLOGY
    17. Yang, SX; Vervaert, CE; Burch, J; Grichnik, J; Seigler, HF; Darrow, TL
      Murine dendritic cells transfected with human gp100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity

      INTERNATIONAL JOURNAL OF CANCER
    18. Dong, XD; DeMatos, P; Prieto, VG; Seigler, HF
      Melanoma of the gallbladder - A review of cases seen at Duke University Medical Center

      CANCER
    19. MOONEY EE; SEIGLER HF; LAYFIELD LJ
      REPORTING FINE-NEEDLE ASPIRATES OF BREAST - A SURVEY OF PREFERENCES AMONG SURGEONS

      Diagnostic cytopathology
    20. DeMatos, P; Tyler, DS; Seigler, HF
      Malignant melanoma of the mucous membranes: A review of 119 cases

      ANNALS OF SURGICAL ONCOLOGY
    21. DEMATOS P; TYLER D; SEIGLER HF
      MUCOSAL MELANOMA OF THE FEMALE GENITALIA - A CLINICOPATHOLOGICAL STUDY OF 43 CASES AT DUKE-UNIVERSITY-MEDICAL-CENTER

      Surgery
    22. SAMPSON JH; CARTER JH; FRIEDMAN AH; SEIGLER HF
      DEMOGRAPHICS, PROGNOSIS, AND THERAPY IN 702 PATIENTS WITH BRAIN METASTASES FROM MALIGNANT-MELANOMA

      Journal of neurosurgery
    23. ABDELWAHAB Z; DEMATOS P; HESTER D; DONG XD; SEIGLER HF
      HUMAN DENDRITIC CELLS, PULSED WITH EITHER MELANOMA TUMOR-CELL LYSATESOR THE GP100 PEPTIDE((280-288)), INDUCE PAIRS OF T-CELL CULTURES WITHSIMILAR PHENOTYPE AND LYTIC ACTIVITY

      Cellular immunology (Print)
    24. DEMATOS P; ABDELWAHAB Z; VERVAERT C; SEIGLER HF
      VACCINATION WITH DENDRITIC CELLS INHIBITS THE GROWTH OF HEPATIC METASTASES IN B6 MICE

      Cellular immunology
    25. ABDELWAHAB Z; DAR M; OSANTO S; FONG T; VERVAERT CE; HESTER D; JOLLY D; SEIGLER HF
      ERADICATION OF MELANOMA PULMONARY METASTASES BY IMMUNOTHERAPY WITH TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-2 OR GAMMA-INTERFERON

      Cancer gene therapy
    26. DEMATOS P; WOLFE WG; SHEA CR; PRIETO VG; SEIGLER HF
      PRIMARY MALIGNANT-MELANOMA OF THE ESOPHAGUS

      Journal of surgical oncology
    27. YANG SX; DARROW TL; VERVAERT CE; SEIGLER HF
      IMMUNOTHERAPEUTIC POTENTIAL OF TUMOR ANTIGEN-PULSED AND UNPULSED DENDRITIC CELLS GENERATED FROM MURINE BONE-MARROW

      Cellular immunology
    28. YANG SX; DARROW TL; SEIGLER HF
      GENERATION OF PRIMARY TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FROM AUTOLOGOUS AND HUMAN LYMPHOCYTE ANTIGEN CLASS I-MATCHED ALLOGENEIC PERIPHERAL-BLOOD LYMPHOCYTES BY B7 GENE-MODIFIED MELANOMA-CELLS

      Cancer research
    29. ABDELWAHAB Z; WELTZ C; HESTER D; PICKETT N; VERVAERT C; BARBER JR; JOLLY D; SEIGLER HF
      A PHASE-I CLINICAL-TRIAL OF IMMUNOTHERAPY WITH INTERFERON-GAMMA GENE-MODIFIED AUTOLOGOUS MELANOMA-CELLS - MONITORING THE HUMORAL IMMUNE-RESPONSE

      Cancer
    30. SEIGLER HF
      ADVANCES IN THE CARE OF THE PATIENT WITH MALIGNANT-MELANOMA

      Annals of surgery
    31. DAR MM; ABDELWAHAB Z; VERVAERT CE; DARROW T; BARBER J; SEIGLER HF
      IMMUNOLOGICAL MEMORY INDUCED BY GENETICALLY TRANSDUCED TUMOR-CELLS

      Annals of surgical oncology
    32. STIDHAM KR; RICCI WM; VERVAERT C; ABDELWAHAB Z; SEIGLER HF; DARROW TL
      MODULATION OF SPECIFIC ACTIVE IMMUNIZATION AGAINST MURINE MELANOMA USING RECOMBINANT CYTOKINES

      Surgical oncology
    33. DARROW TL; ABDELWAHAB Z; QUINNALLEN MA; SEIGLER HF
      RECOGNITION AND LYSIS OF HUMAN-MELANOMA BY A CD3(-) T-CELL CLONE RESTRICTED BY HLA-A2(), CD4(+), CD8()

      Cellular immunology
    34. ABDELWAHAB Z; DAR MM; HESTER D; VERVAERT C; GANGAVALLI R; BARBER J; DARROW TL; SEIGLER HF
      EFFECT OF IRRADIATION ON CYTOKINE PRODUCTION, MHC ANTIGEN EXPRESSION,AND VACCINE POTENTIAL OF INTERLEUKIN-2 AND INTERFERON-GAMMA GENE-MODIFIED MELANOMA-CELLS

      Cellular immunology
    35. CHARI RS; TYLER DS; ANSCHER MS; RUSSEL L; CLARY BM; HATHORN J; SEIGLER HF
      UNTITLED - REPLY

      Annals of surgery
    36. SPIEGEL DA; SAMPSON JH; RICHARDSON WJ; FRIEDMAN AH; ROSSITCH E; HARDAKER WT; SEIGLER HF
      METASTATIC MELANOMA TO THE SPINE - DEMOGRAPHICS, RISK-FACTORS, AND PROGNOSIS IN 114 PATIENTS

      Spine (Philadelphia, Pa. 1976)
    37. SAMPSON JH; FRIEDMAN AH; SEIGLER HF
      DEMOGRAPHICS, TREATMENT, AND PROGNOSIS OF 76 PATIENTS WITH PRIMARY INTRACEREBRAL MELANOMA

      Journal of neurosurgery
    38. CHARI RS; TYLER DS; ANSCHER MS; RUSSELL L; CLARY BM; HATHORN J; SEIGLER HF
      PREOPERATIVE RADIATION AND CHEMOTHERAPY IN THE TREATMENT OF ADENOCARCINOMA OF THE RECTUM

      Annals of surgery
    39. DAVIDOFF AM; CIRRINCIONE C; SEIGLER HF
      MALIGNANT-MELANOMA IN CHILDREN

      Annals of surgical oncology
    40. SEIGLER HF; DARROW TL; ABDELWAHAB Z; GANGAVALLI R; BARBER J
      A PHASE-I TRIAL OF HUMAN GAMMA-INTERFERON TRANSDUCED AUTOLOGOUS TUMOR-CELLS IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA

      Human gene therapy
    41. ABDELWAHAB ZA; OSANTO S; DARROW TL; BARBER JR; VERVAERT CE; GANGAVALLI R; MCCALLISTER TJ; SEIGLER HF
      TRANSDUCTION OF HUMAN-MELANOMA CELLS WITH THE GAMMA-INTERFERON GENE ENHANCES CELLULAR-IMMUNITY

      Cancer gene therapy
    42. SAMPSON JH; SPIEGEL DA; ROSSITCH E; RICHARDSON W; FRIEDMAN AH; SEIGLER HF
      METASTATIC MELANOMA OF THE SPINE - DEMOGRAPHICS, RISK-FACTORS, TREATMENT RESULTS, AND PROGNOSIS

      Journal of neurosurgery
    43. BARNES BC; SEIGLER HF; SAXBY TS; KOCHER MS; HARRELSON JM
      MELANOMA OF THE FOOT

      Journal of bone and joint surgery. American volume
    44. ABDELWAHAB Z; LI WP; OSANTO S; DARROW TL; HESSLING J; VERVAERT CE; BURRASCANO M; BARBER J; SEIGLER HF
      TRANSDUCTION OF HUMAN-MELANOMA CELLS WITH INTERLEUKIN-2 GENE REDUCES TUMORIGENICITY AND ENHANCES HOST ANTITUMOR IMMUNITY - A NUDE-MOUSE MODEL

      Cellular immunology
    45. HUSAIN I; MOHLER JL; SEIGLER HF; BESTERMAN JM
      ELEVATION OF TOPOISOMERASE-I MESSENGER-RNA, PROTEIN, AND CATALYTIC ACTIVITY IN HUMAN TUMORS - DEMONSTRATION OF TUMOR-TYPE SPECIFICITY AND IMPLICATIONS FOR CANCER-CHEMOTHERAPY

      Cancer research
    46. STIDHAM KR; JOHNSON JL; SEIGLER HF
      SURVIVAL SUPERIORITY OF FEMALES WITH MELANOMA - A MULTIVARIATE-ANALYSIS OF 6383 PATIENTS EXPLORING THE SIGNIFICANCE OF GENDER IN PROGNOSTICOUTCOME

      Archives of surgery
    47. STIDHAM KR; JOHNSON JL; SEIGLER HF
      SURVIVAL SUPERIORITY OF FEMALES WITH MELANOMA - REPLY

      Archives of surgery
    48. REINTGEN D; CRUSE CW; WELLS K; BERMAN C; FENSKE N; GLASS F; SCHROER K; HELLER R; ROSS M; LYMAN G; COX C; RAPPAPORT D; SEIGLER HF; BALCH C
      THE ORDERLY PROGRESSION OF MELANOMA NODAL METASTASES

      Annals of surgery
    49. SLINGLUFF CL; STIDHAM KR; RICCI WM; STANLEY WE; SEIGLER HF
      SURGICAL-MANAGEMENT OF REGIONAL LYMPH-NODES IN PATIENTS WITH MELANOMA- EXPERIENCE WITH 4682 PATIENTS

      Annals of surgery
    50. REINTGEN D; ROSS M; BLAND K; SEIGLER HF; BALCH C
      PREVENTION AND EARLY DETECTION OF MELANOMA - A SURGEONS PERSPECTIVE

      Seminars in surgical oncology
    51. CROWLEY NJ; SEIGLER HF
      POSSIBILITIES OF IMMUNOTHERAPY AND GENE-THERAPY FOR MALIGNANT-MELANOMA

      Seminars in surgical oncology
    52. ABDELWAHAB Z; LI WP; DARROW T; NUDELMAN ED; TOWELL A; SEIGLER HF
      CELL-SURFACE REACTIVE HUMAN MONOCLONAL-ANTIBODY DIRECTED TO HUMAN MELANOMA-ASSOCIATED GANGLIOSIDES

      Melanoma research
    53. LANGFORD FPJ; FISHER SR; MOLTER DW; SEIGLER HF
      LENTIGO-MALIGNA MELANOMA OF THE HEAD AND NECK

      The Laryngoscope
    54. GAMEL JW; GEORGE SL; STANLEY WE; SEIGLER HF
      CURED FRACTION AND SURVIVAL-TIME AS FUNCTIONS OF THICKNESS, SITE, HISTOLOGIC TYPE, AGE, AND SEX

      Cancer
    55. MEISENBERG BR; ROSS M; VREDENBURGH JJ; JONES R; SHPALL EJ; SEIGLER HF; CONIGLIO DM; WU K; PETERS WP
      RANDOMIZED TRIAL OF HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT AS ADJUVANT THERAPY FOR HIGH-RISK, MULTI-NODE-POSITIVE MALIGNANT-MELANOMA

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 08:45:50